A crisis of innovation grips "the entire biomedical research enterprise," according to the leader of the Vanderbilt Program in Drug Discovery.

VPDD Director Jeff Conn, Ph.D., told VNC during an interview Friday that, despite gains on many fronts, extraordinary opportunities to improve medicine are being hampered by academic and industrial culture, and undermined by the failure of old business models that have long been employed by those attempting to translate scientific knowledge into better medicines.

Read More: VU's Conn advocates new models for drug discovery